USRE33420E - System for controlling an implanted neural stimulator - Google Patents

System for controlling an implanted neural stimulator Download PDF

Info

Publication number
USRE33420E
USRE33420E US07/247,131 US24713188A USRE33420E US RE33420 E USRE33420 E US RE33420E US 24713188 A US24713188 A US 24713188A US RE33420 E USRE33420 E US RE33420E
Authority
US
United States
Prior art keywords
output current
iaddend
iadd
level
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/247,131
Inventor
Marvin L. Sussman
Barry M. Yomtov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cordis Corp
Original Assignee
Cordis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cordis Corp filed Critical Cordis Corp
Priority to US07/247,131 priority Critical patent/USRE33420E/en
Application granted granted Critical
Publication of USRE33420E publication Critical patent/USRE33420E/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile

Definitions

  • the present invention relates generally to medical electronic apparatus for applying electrical current to living tissue including programmable apparatus for controlling the electrical current applied therein. More particularly, the present invention relates to a system for controlling the current supplied to an implanted electrode within a body for electrically stimulating a nerve.
  • Implantable apparatus have been developed in recent years which include an electrode implantable within a living body for electrically stimulating a nerve. Such an apparatus is disclosed in U.S. Pat. No. 3,822,708.
  • an implantable electrode-carrying device is arranged to be positioned on the spinal cord so that an electric current can be passed through an electrode into a portion of the juxtaposed spinal cord area. The passage of the current into the nerve acts to block electrical pain signals.
  • Implantable cardiac pacers have utilized programmable devices to establish a desired output in response to transmitted programming signals. Such a device is described in U.S. Pat. No. 4,253,466, where a radio frequency transmitter is used to program an implanted pacemaker. Once programmed, a magnetic field actuated reed relay is used to provide temporary reprogramming and is operable to reset the output to the original setting when the magnetic field is removed.
  • a timing cycle is permanently programmed within an implanted microprocessor to interact with a magnetically actuated reed relay for selective alteration of the amplitude of the stimulator output.
  • a neural stimulator system including electrode to nerve electrical connections and circuitry as discussed in the prior art (U.S. Pat. Nos. 3,896,817 and 3,841,306) are implanted in a patient.
  • a microprocessor is also implanted beneath the skin of the patient to control the neural stimulator and is programmed to provide a desired output range.
  • the programmed microprocessor monitors the status of a magnetically controlled reed switch implanted proximate the skin surface of the patient to select a desired output. Application of a magnet to the surface of the skin closes the reed switch and this closure is sensed by the microprocessor.
  • the neural stimulator is turned to the "on" state.
  • the application of the magnet over the reed switch for a second period of time such as from 2 to 6 seconds, will be sensed by the microprocessor as an instruction to turn the neural stimulator to the "off" state.
  • Application of the magnet for a third period of time such as some period greater than 6 seconds, causes the output generated by the neural stimulator to increase incrementally from zero up to a preprogrammed maximum output.
  • the magnet is removed and the generated output remains at the level attained at the time of the magnet removal.
  • Such controllability has been found to be highly desirable since neural stimulation can be lost and pain may return when a patient changes positions. In such an instance, the patient can apply the magnet over the implanted neural stimulator to increase the output to a higher selected level to remove the pain.
  • FIG. 1 is a partially perspective mechanical and partially schematic view of a magnet adjacent an implanted megnetically controlled microprocessor which is actuated by an implanted reed switch for controlling a neural stimulator;
  • FIG. 2 is a timing diagram of the microprocessor control intervals
  • FIG. 3 is a graph of the microprocessor controlled output current versus time
  • FIG. 4 is an enlarged fragmentary graphical view of the output current pulses shown in FIG. 3;
  • FIG. 5 is a flow chart of the program or protocol of the microprocessor.
  • an implanted neural stimulating apparatus 10 including a microprocessor 11.
  • the microprocessor 11 is implanted within living tissue 12 beneath the skin 14 and controls a neural stimulator including electrodes for carrying electrical current to the nerves in accordance with commonly known principles of neural stimulation.
  • a neural stimulator and an electrode for implantation in a spine adjacent a spinal cord are old in the art. See Hagfors U.S. Pat. No. 3,645,267 issued Feb. 29, 1972 and Hess U.S. Pat. No. 4,285,347 issued Aug. 25, 1981, the disclosures of which are incorporated herein by reference.
  • a magnetically actuated reed switch 16 Electrically coupled to the microprocessor 11 and implanted within the tissue 12 proximate the skin 14 is a magnetically actuated reed switch 16.
  • the reed switch 16 is controlled and switched from its open state to its closed state through application of an external magnet 20.
  • a magnetic field 22 of the magnet 20 penetrates the skin 14 and the tissue 12 to close the reed switch 16.
  • the closing of the reed switch 16 is sensed by the microprocessor 11 and the sensing initiates a timing cycle, as shown in FIG. 2.
  • the reed switch 16 will reopen and the open condition will be sensed by the microprocessor 11 as an instruction to turn the neural stimulator to its "on" state.
  • the reopening of the reed switch 16 within that period of time is sensed by the microprocessor 11 as an instruction to turn the neural stimulator to an "off" state.
  • FIG. 3 is a graph of increasing amplitude of output current (ramp 24) over a period of time.
  • the output current is plotted on the vertical axis increasing from 0 to 8.9 milliamps and the time is plotted on the horizontal axis increasing from 6 seconds to 36 seconds.
  • an output current is selected by the microprocessor according to the graph shown in FIG. 3.
  • Microprocessor control of a neural stimulator is old in the art. See the Rise U.S. Pat. No. 4,390,023 issued June 28, 1983, the disclosure of which is incorporated herein by reference.
  • the microprocessor 11 is programmed to periodically increase the output current in increments, such as 0.12 milliamps, each 0.042 second, until the maximum output permanently programmed in the microprocessor is reached. Additionally, the output is generated in a series of three pulses 30, 33, etc. (FIG. 4) such that each burst of three pulses would be incrementally greater than the previous burst.
  • the rate of stimulation and the level of output current of amplitude can be changed non-invasively by a physician at implantation or during subsequent office visits.
  • a totally dedicated device such as a programmer or microprocessor is used.
  • the patient and/or the physician can activate or de-activate the output of the implanted neural stimulator by the application of a magnet.
  • the patient cannot magnetically change the output level to unsafe levels because the physician has preset the maximum output current/amplitude capable of being output by the neural stimulator apparatus 10 controlled by the microprocessor 11
  • the physician can program the apparatus to "on” and to a desired rate an output current.
  • a patient or a physician could turn an implanted neural stimulator to "off” and at a later time to “on” by applying a magnet over the stimulator.
  • the stimulator was “on”
  • application of the magnet for 2 to 6 seconds would turn the unit “off”.
  • the implanted neural stimulator would be turned “on” by application of the magnet for 0.003 to 1 second.
  • the output current and rate would then be those which were programmed by the physician.
  • the magnetic ramp function e.g. ramp 24
  • the magnet 20 for periods greater than 6 seconds causes the output current to increase incrementally from 0 to the maximum programmed output current.
  • the magnet 20 is removed and stimulation occurs at that output current level which was obtained at the time of the removal of the magnet 20.
  • the output current 24 will never exceed the maximum current programmed.
  • the patient can apply the magnet 20 over the implanted neural stimulating apparatus 10 to increase the output current to a higher level or to a more effective level.
  • the program or protocol carried out by the microprocessor 11 in response to magnet control or positioning of the magnet 20 adjacent to the neural stimulating apparatus 10 is shown in FIG. 5.
  • the steps followed in executing the program are as follows:
  • Step 1 the microprocessor 11 determines whether the program is "on” or "off". For example, if the current output was at the maximum level established by the physician the program would be “off” and the program would go to "yes” output and end or exit the program. If the program is not "off", the microprocessor 11 then goes to Step 2.
  • Step 2 the microprocessor 11 monitors the status of the reed switch 16 and then goes on to Step 3.
  • Step 3 the microprocessor 11 determines whether the reed switch 16 is still closed. If it is, the program goes on to Step 4.
  • Step 4 the microprocessor 11 determines whether more than 6 seconds have elapsed. If “no” the program loops back to Step 2. If “yes” the program goes on to Step 10.
  • Step 3 the program or microprocessor 11 determines whether it has been closed for 2 seconds. If "yes” the program goes on to Step 6.
  • STEP 6 Here the program turns off the neural stimulating apparatus 10 and ends or exits the program.
  • Step 7 If the answer to Step 5 was "no" the microprocessor 11 then determines whether the switch 16 had been closed for less than 1 second. If the answer is "no" the microprocessor ends or exits the program.
  • STEP 9 Here the current amplitude is returned to the originally programmed value and from there the microprocessor 11 ends or exits the program.
  • Step 10 If at Step 5 the switch 16 had been closed for more than 6 seconds, the microprocessor 11 goes on to Step 10 and a determination is made as to whether or not the output current is on. If “yes”, the microprocessor 11 exits or ends the program. If “no” it goes on to Step 11.
  • STEP 11 At this step, a determination is made if the magnetic ramp function, i.e., ramp 24, is set. If “no” the microprocessor 11 ends or exits the program. If “yes” the microprocessor 11 goes on to Step 12.
  • the magnetic ramp function i.e., ramp 24
  • Step 13 the microprocessor 11 determines whether or not the reed switch 16 is still closed. If “no” the microprocessor 11 ends or exits the program. If “yes” the microprocessor 11 goes on to Step 14.
  • Step 14 the microprocessor 11 causes the value of the output current to increase in levels or steps with three amplitude bursts for each level of increase (such as the amplitude burst 30 and 33 shown in FIG. 4). This will occur until the magnet 20 is removed or the microprocessor 11 makes a determination in Step 15 that the upper level of current has been reached.
  • Step 14 the microprocessor 11 is monitoring the increase in current amplitude and when it determines that the amplitude of the current has not reached the maximum amplitude of the current the microprocessor 11 loops back to the beginning of Step 13. If on the other hand, the microprocessor 11 determines that the maximum current of amplitude has been reached, the microprocessor ends or exits the program to stop further increases in output current level.
  • the neural stimulating apparatus 10 of the present invention and the method for using same allow either the patient or the physician to alter the level of output current using an external magnet 20.
  • Such use of the external magnet 20 for the predetermined period of time initiates an incrementally increasing output current under control of a program in an implanted microprocessor 11, allowing the patient to determine the effective level of output current for efficacious stimulation and then fix the level of the output current at that selected level.
  • the microprocessor 11 is programmed to limit the upper value of output current that can be supplied to electrodes adjacent nerves to be stimulated so that such output current cannot reach an unsafe level.

Abstract

An improved control system for a neural stimulator allowing either the patient or physician to effect the level of output by application of an external magnet. Such application of a magnet for a predetermined period of time initiates an incrementally increasing output, under control of an implanted microprocessor, allowing human feedback from the patient to determine the effective level of output current to fix the output at the selected effective level.

Description

.Iadd.This application is a Reissue of application No. 06/924,743 filed on 10/30/86 and issued as U.S. Pat. No. 4,735,204. .Iaddend.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to medical electronic apparatus for applying electrical current to living tissue including programmable apparatus for controlling the electrical current applied therein. More particularly, the present invention relates to a system for controlling the current supplied to an implanted electrode within a body for electrically stimulating a nerve.
2. Description of the Prior Art
Implantable apparatus have been developed in recent years which include an electrode implantable within a living body for electrically stimulating a nerve. Such an apparatus is disclosed in U.S. Pat. No. 3,822,708. In this apparatus, an implantable electrode-carrying device is arranged to be positioned on the spinal cord so that an electric current can be passed through an electrode into a portion of the juxtaposed spinal cord area. The passage of the current into the nerve acts to block electrical pain signals.
More recently, there has been described in U.S. Pat. No. 4,323,073 an apparatus for controlling the direct current applied to living tissue and a method for increasing the current to a predetermined level for a period of time and then decreasing the current. In this manner, no nerve reaction or spasm is caused while the appropriate stimuli is provided for the reduction of pain. This method, however, provides only an automatically modulated output at only one or two levels and does not provide for patient or physician control of the level of stimulation.
Implantable cardiac pacers have utilized programmable devices to establish a desired output in response to transmitted programming signals. Such a device is described in U.S. Pat. No. 4,253,466, where a radio frequency transmitter is used to program an implanted pacemaker. Once programmed, a magnetic field actuated reed relay is used to provide temporary reprogramming and is operable to reset the output to the original setting when the magnetic field is removed.
SUMMARY OF THE INVENTION
According to the teaching of the present invention, there is provided a system for controlling an implanted neural stimulator by an externally applied magnetic means. With this system a timing cycle is permanently programmed within an implanted microprocessor to interact with a magnetically actuated reed relay for selective alteration of the amplitude of the stimulator output.
A neural stimulator system including electrode to nerve electrical connections and circuitry as discussed in the prior art (U.S. Pat. Nos. 3,896,817 and 3,841,306) are implanted in a patient. A microprocessor is also implanted beneath the skin of the patient to control the neural stimulator and is programmed to provide a desired output range. The programmed microprocessor monitors the status of a magnetically controlled reed switch implanted proximate the skin surface of the patient to select a desired output. Application of a magnet to the surface of the skin closes the reed switch and this closure is sensed by the microprocessor. If the magnet is removed and the reed switch reopens within a short time, such as within a 0.003 second to 1 second time period, the neural stimulator is turned to the "on" state. The application of the magnet over the reed switch for a second period of time, such as from 2 to 6 seconds, will be sensed by the microprocessor as an instruction to turn the neural stimulator to the "off" state. Application of the magnet for a third period of time, such as some period greater than 6 seconds, causes the output generated by the neural stimulator to increase incrementally from zero up to a preprogrammed maximum output. At a point where the patient and physician determine that the magnitude of the stimulation is sufficient, the magnet is removed and the generated output remains at the level attained at the time of the magnet removal. Such controllability has been found to be highly desirable since neural stimulation can be lost and pain may return when a patient changes positions. In such an instance, the patient can apply the magnet over the implanted neural stimulator to increase the output to a higher selected level to remove the pain.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a partially perspective mechanical and partially schematic view of a magnet adjacent an implanted megnetically controlled microprocessor which is actuated by an implanted reed switch for controlling a neural stimulator;
FIG. 2 is a timing diagram of the microprocessor control intervals;
FIG. 3 is a graph of the microprocessor controlled output current versus time;
FIG. 4 is an enlarged fragmentary graphical view of the output current pulses shown in FIG. 3; and
FIG. 5 is a flow chart of the program or protocol of the microprocessor.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to FIG. 1, there is illustrated therein an implanted neural stimulating apparatus 10 including a microprocessor 11. The microprocessor 11 is implanted within living tissue 12 beneath the skin 14 and controls a neural stimulator including electrodes for carrying electrical current to the nerves in accordance with commonly known principles of neural stimulation. A neural stimulator and an electrode for implantation in a spine adjacent a spinal cord are old in the art. See Hagfors U.S. Pat. No. 3,645,267 issued Feb. 29, 1972 and Hess U.S. Pat. No. 4,285,347 issued Aug. 25, 1981, the disclosures of which are incorporated herein by reference. Electrically coupled to the microprocessor 11 and implanted within the tissue 12 proximate the skin 14 is a magnetically actuated reed switch 16. The reed switch 16 is controlled and switched from its open state to its closed state through application of an external magnet 20. A magnetic field 22 of the magnet 20 penetrates the skin 14 and the tissue 12 to close the reed switch 16.
The closing of the reed switch 16 is sensed by the microprocessor 11 and the sensing initiates a timing cycle, as shown in FIG. 2.
If the magnet 20 is removed within a first period of time, such as 0.003 second to 1 second, the reed switch 16 will reopen and the open condition will be sensed by the microprocessor 11 as an instruction to turn the neural stimulator to its "on" state.
If the magnet 20 is held in place for a period of time exceeding 2 seconds but less than 6 seconds and then removed, the reopening of the reed switch 16 within that period of time is sensed by the microprocessor 11 as an instruction to turn the neural stimulator to an "off" state.
In the event the magnet 20 is held in place against the skin for a period of time greater than 6 seconds, this is sensed by the microprocessor 11 as a signal to begin generation of an output signal periodically increasing in magnitude according to a ramp function and referred to as a magnetic ramp 24.
FIG. 3 is a graph of increasing amplitude of output current (ramp 24) over a period of time. The output current is plotted on the vertical axis increasing from 0 to 8.9 milliamps and the time is plotted on the horizontal axis increasing from 6 seconds to 36 seconds.
Accordingly, if the magnet 20 is held in place for a period greater than 6 seconds but less than 36 seconds, an output current is selected by the microprocessor according to the graph shown in FIG. 3. Microprocessor control of a neural stimulator is old in the art. See the Rise U.S. Pat. No. 4,390,023 issued June 28, 1983, the disclosure of which is incorporated herein by reference.
In the preferred embodiment of the present invention, during the generation of the output current ramp 24, the microprocessor 11 is programmed to periodically increase the output current in increments, such as 0.12 milliamps, each 0.042 second, until the maximum output permanently programmed in the microprocessor is reached. Additionally, the output is generated in a series of three pulses 30, 33, etc. (FIG. 4) such that each burst of three pulses would be incrementally greater than the previous burst.
Heretofore, in the use of certain implantable neural stimulators, the rate of stimulation and the level of output current of amplitude can be changed non-invasively by a physician at implantation or during subsequent office visits. To effect these changes, a totally dedicated device such as a programmer or microprocessor is used. In addition, the patient and/or the physician can activate or de-activate the output of the implanted neural stimulator by the application of a magnet.
However, changes in the patient's position such as from sitting to standing, can cause cessation of efficacious stimulation. In such instances, an office visit to the physician is necessary for re-programming of the implanted neural stimulator to change the output of the stimulator. With the system of the present invention for controlling an implanted neural stimulator, the capability of changing the output current levels within a programmed output current range by use of an externally applied magnet 20 is provided, and the frequency of office visits can be decreased. The patient can then choose that output current level which is most efficacious for both activity level and physical position.
Also, the patient cannot magnetically change the output level to unsafe levels because the physician has preset the maximum output current/amplitude capable of being output by the neural stimulator apparatus 10 controlled by the microprocessor 11
With the neural stimulating apparatus 10 of the present invention, after implantation of the apparatus 10, the physician can program the apparatus to "on" and to a desired rate an output current.
Previously a patient or a physician could turn an implanted neural stimulator to "off" and at a later time to "on" by applying a magnet over the stimulator. When the stimulator was "on", application of the magnet for 2 to 6 seconds would turn the unit "off". Conversely, when the neural stimulator was in "off" mode, the implanted neural stimulator would be turned "on" by application of the magnet for 0.003 to 1 second. The output current and rate would then be those which were programmed by the physician.
In accordance with the teachings of the present invention, addition of the magnetic ramp function (e.g. ramp 24), whose duration is programmed using a dedicated external device by a physician permits the patient and/or the physician to change the output current amplitude. Application of the magnet 20 for periods greater than 6 seconds causes the output current to increase incrementally from 0 to the maximum programmed output current. At a point where the patient and/or the physician determines that the magnitude of the stimulation is efficacious but before the end of the magnetic ramp duration, the magnet 20 is removed and stimulation occurs at that output current level which was obtained at the time of the removal of the magnet 20. The output current 24 will never exceed the maximum current programmed.
When a patient changes position from sitting to standing and finds that neural stimulation is lost, e.g. return of pain, the patient can apply the magnet 20 over the implanted neural stimulating apparatus 10 to increase the output current to a higher level or to a more effective level.
The program or protocol carried out by the microprocessor 11 in response to magnet control or positioning of the magnet 20 adjacent to the neural stimulating apparatus 10 is shown in FIG. 5. The steps followed in executing the program are as follows:
STEP 1. At this step the microprocessor 11 determines whether the program is "on" or "off". For example, if the current output was at the maximum level established by the physician the program would be "off" and the program would go to "yes" output and end or exit the program. If the program is not "off", the microprocessor 11 then goes to Step 2.
STEP 2. At this step, the microprocessor 11 monitors the status of the reed switch 16 and then goes on to Step 3.
STEP 3. Here the microprocessor 11 determines whether the reed switch 16 is still closed. If it is, the program goes on to Step 4.
STEP 4. Here the microprocessor 11 determines whether more than 6 seconds have elapsed. If "no" the program loops back to Step 2. If "yes" the program goes on to Step 10.
STEP 5. If at Step 3 the reed switch is not still closed, the program or microprocessor 11 determines whether it has been closed for 2 seconds. If "yes" the program goes on to Step 6.
STEP 6. Here the program turns off the neural stimulating apparatus 10 and ends or exits the program.
STEP 7. If the answer to Step 5 was "no" the microprocessor 11 then determines whether the switch 16 had been closed for less than 1 second. If the answer is "no" the microprocessor ends or exits the program.
STEP 8. If the answer is "yes", the neural stimulator is turned on and the microprocessor 11 goes on to Step 9.
STEP 9. Here the current amplitude is returned to the originally programmed value and from there the microprocessor 11 ends or exits the program.
STEP 10. If at Step 5 the switch 16 had been closed for more than 6 seconds, the microprocessor 11 goes on to Step 10 and a determination is made as to whether or not the output current is on. If "yes", the microprocessor 11 exits or ends the program. If "no" it goes on to Step 11.
STEP 11. At this step, a determination is made if the magnetic ramp function, i.e., ramp 24, is set. If "no" the microprocessor 11 ends or exits the program. If "yes" the microprocessor 11 goes on to Step 12.
STEP 12. Here the output current is reset to zero.
STEP 13. Here the microprocessor 11 determines whether or not the reed switch 16 is still closed. If "no" the microprocessor 11 ends or exits the program. If "yes" the microprocessor 11 goes on to Step 14.
STEP 14. At this step, the microprocessor 11 causes the value of the output current to increase in levels or steps with three amplitude bursts for each level of increase (such as the amplitude burst 30 and 33 shown in FIG. 4). This will occur until the magnet 20 is removed or the microprocessor 11 makes a determination in Step 15 that the upper level of current has been reached.
STEP 15. At Step 14 the microprocessor 11 is monitoring the increase in current amplitude and when it determines that the amplitude of the current has not reached the maximum amplitude of the current the microprocessor 11 loops back to the beginning of Step 13. If on the other hand, the microprocessor 11 determines that the maximum current of amplitude has been reached, the microprocessor ends or exits the program to stop further increases in output current level.
From the foregoing description, it will be apparent that the neural stimulating apparatus 10 of the present invention and the method for using same allow either the patient or the physician to alter the level of output current using an external magnet 20. Such use of the external magnet 20 for the predetermined period of time initiates an incrementally increasing output current under control of a program in an implanted microprocessor 11, allowing the patient to determine the effective level of output current for efficacious stimulation and then fix the level of the output current at that selected level. Further, the microprocessor 11 is programmed to limit the upper value of output current that can be supplied to electrodes adjacent nerves to be stimulated so that such output current cannot reach an unsafe level.
Further from the foregoing description, it will be apparent that modifications can be made to the apparatus 10 and method for using same without departing from the teachings of the present invention. Accordingly, the scope of the invention is only to be limited as necessitated by the accompanying claims.

Claims (17)

I claim:
1. A neural stimulating system for permitting patient control of a neural stimulator within preset limits in response to an externally and manually applied magnetic field, said neural stimulating system comprising:
a magnet for use by the patient;
a magnetically controlled switch for implantation in a patient's body just beneath the patient's skin and for being positioned at a location in the body for selective closing by application of an external magnetic field as established by placing said magnet over the patient's skin adjacent said switch;
a neural stimulating electrode for implantation in a patient's spine adjacent the patient's spinal cord; and
a neural stimulator including programmable electronic circuit means for implantation in a patient's body, such as adjacent said switch, said circuit means being electrically coupled to said magnetically controlled switch and to said neural stimulating electrode and said circuit means including means for generating .[.a selective.]. .Iadd.neural stimulating .Iaddend.electrical output current .Iadd.pulses of a selected magnitude .Iaddend.between a minimum level of .[.zero.]. current, programmed into said circuit means and a maximum level .Iadd.of current .Iaddend.programmed .[.by a physician.]. into said circuit means in response to closing of and duration of the closure of said magnetically controlled switch, .[.which.]. .Iadd.the .Iaddend.output current .Iadd.pulses being .Iaddend..[.is.]. supplied to said neural stimulating electrode,
said means for generating .[.an.]. output current .Iadd.pulses .Iaddend.including means for .[.generating.]. gradually.[.,.]. .Iadd.and .Iaddend.incrementally .[.increasing.]. .Iadd.changing the magnitude of the .Iaddend.neural stimulating electrical output current pulses, in response to the application of the externally applied magnetic field to said magnetically controlled switch for a predetermined period of time.
2. The system of claim 1 wherein said means for .[.generating gradually, incrementally increasing.]. .Iadd.changing the magnitude of the .Iaddend.neural stimulating electrical output current pulses includes means for generating current pulses along a ramp function.
3. The system of claim 1 wherein said electronic circuit means .[.comprises.]. .Iadd.comprise .Iaddend.means for detecting the electrical output current being generated at the time of removal of the externally applied magnetic field and the opening of said magnetic actuated switch and for maintaining said output current at the detected level.
4. The system of claim 3 wherein said implanted circuit means comprises a microprocessor coupled to said switch and to said current generating means.
5. The system of claim 4 wherein said microprocessor includes means for detecting the opening and closing of the magnetically actuated switch and means for turning the neural stimulator .[.or.]. .Iadd.on .Iaddend.in response to closure of said switch for a first duration, means for turning the neural stimulator off in response to a closure of said switch for a second duration following immediately after said first duration, and means for initiating .[.an incrementally increasing.]. .Iadd.said means for changing the magnitude of the .Iaddend.neural stimulator output current .Iadd.pulses .Iaddend.in response to a closure of said switch for a third duration following immediately after said second duration.
6. A method for controlling, by a patient, the operation of a neural stimulating system including a magnet, a neural stimulator implanted in a patient's spine including current generating means, a microprocessor implanted beneath a patient's skin coupled to said current generating means and a magnetically responsive reed switch means implanted beneath a patient's skin and connected to the microprocessor, said method comprising the steps of:
manually causing, from a position exterior of a patient's body, closing of the reed switch means for a predetermined time period by holding the magnet adjacent said reed switch means for said predetermined time period;
generating output current pulses from the neural stimulator;
and
causing the output current pulses from the neural stimulator to increase incrementally from a minimum .Iadd.programmed level .Iaddend..[.value of 0.]. so long as the reed switch means is closed beyond the predetermined time period and only until a certain current level is reached.Iadd., .Iaddend.which is the lesser of a level of output current that interrupts human body generated pain pulses and a maximum output current level of the neural stimulator preprogrammed by a physician into the microprocessor;
said step of causing the output current pulses to increase including the step of utilizing means for gradually and incrementally increasing the output current pulses to increase the output current pulses incrementally to successively higher current values.
7. The method according to claim 6 wherein said predetermined time period is at least 6 seconds.
8. The method of claim 6 wherein said step of incrementing the output current pulses is carried out over a time period of a ramp function for current values .[.from 0 milliamps.]. .Iadd.up .Iaddend.to a maximum .[.of 8.9 milliamps.]. .Iadd.current level.Iaddend..
9. The method of claim 6 wherein said step of incrementing the output current pulses is carried out according to a ramp function which is started at a time approximately 6 seconds after initial closing of the switch means and is continued for a duration of 30 seconds for a total switch means closed period of 36 seconds.
10. The method of claim 6 wherein said step of causing the output current pulses from the neural stimulator to increase includes the step of gradually and incrementally increasing the output current pulses along the slope of a ramp function from .[.0.]. .Iadd.said minimum programmed output current level .Iaddend.to said maximum programmed output current level.
11. The method of claim 10 wherein said step of incrementally increasing the output current pulses includes incrementally increasing the output current in steps of 0.12 milliamps per step along the ramp function.
12. The method of claim 10 wherein said ramp function has a duration of 30 seconds.
13. The method of claim 10 wherein said output current increases over the .[.timer.]. .Iadd.time .Iaddend.period of said ramp function from .[.0.]. .Iadd.said minimum programmed output current level .Iaddend.to a maximum .[.of 8.9 milliamps.]. .Iadd.current level.Iaddend..
14. The method of claim 6 wherein said step of incrementing the output current pulses in steps includes generating 3 bursts of output current pulses at one level followed by 3 bursts of current pulses at a next succeeding level approximately 0.12 milliamps above the preceding level.
15. The method of claim 14 where the step of generating 3 current pulses includes generating said current pulses over a time period of 0.024 seconds for each step increase in current.
16. The method of claim 10 wherein said step of incrementally increasing the output current pulses includes increasing the output current pulses over a time period of said ramp function from .[.0 milliamps.]. .Iadd.said programmed minimum output current .Iaddend.to a maximum .[.of 8.9 milliamps.]. .Iadd.current level.Iaddend..
17. The method of claim 6 wherein said step of closing the switch means for a time period of more than 2 seconds and less than 6 seconds includes turning off the neural stimulator.
US07/247,131 1984-09-17 1988-09-12 System for controlling an implanted neural stimulator Expired - Lifetime USRE33420E (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/247,131 USRE33420E (en) 1984-09-17 1988-09-12 System for controlling an implanted neural stimulator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65143484A 1984-09-17 1984-09-17
US07/247,131 USRE33420E (en) 1984-09-17 1988-09-12 System for controlling an implanted neural stimulator

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US65143484A Continuation 1984-09-17 1984-09-17
US06/924,743 Reissue US4735204A (en) 1984-09-17 1986-10-30 System for controlling an implanted neural stimulator

Publications (1)

Publication Number Publication Date
USRE33420E true USRE33420E (en) 1990-11-06

Family

ID=26938473

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/247,131 Expired - Lifetime USRE33420E (en) 1984-09-17 1988-09-12 System for controlling an implanted neural stimulator

Country Status (1)

Country Link
US (1) USRE33420E (en)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013592A1 (en) * 1991-02-01 1992-08-20 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5263480A (en) * 1991-02-01 1993-11-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US6246912B1 (en) 1996-06-27 2001-06-12 Sherwood Services Ag Modulated high frequency tissue modification
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US20050004628A1 (en) * 2002-03-15 2005-01-06 Medtronic, Inc Amplitude ramping of waveforms generated by an implantable medical device
USRE40279E1 (en) 1997-06-26 2008-04-29 Sherwood Services Ag Method and system for neural tissue modification
USRE41045E1 (en) 1996-06-27 2009-12-15 Covidien Ag Method and apparatus for altering neural tissue function
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
US7722601B2 (en) 2003-05-01 2010-05-25 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US7749217B2 (en) 2002-05-06 2010-07-06 Covidien Ag Method and system for optically detecting blood and controlling a generator during electrosurgery
US7766693B2 (en) 2003-11-20 2010-08-03 Covidien Ag Connector systems for electrosurgical generator
US7766905B2 (en) 2004-02-12 2010-08-03 Covidien Ag Method and system for continuity testing of medical electrodes
US7780662B2 (en) 2004-03-02 2010-08-24 Covidien Ag Vessel sealing system using capacitive RF dielectric heating
US7824400B2 (en) 2002-12-10 2010-11-02 Covidien Ag Circuit for controlling arc energy from an electrosurgical generator
US7901400B2 (en) 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
US8104956B2 (en) 2003-10-23 2012-01-31 Covidien Ag Thermocouple measurement circuit
US8355792B2 (en) 2009-04-22 2013-01-15 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8509906B2 (en) 2009-01-29 2013-08-13 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8649874B2 (en) 2010-11-30 2014-02-11 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US8768472B2 (en) 2007-11-05 2014-07-01 Nevro Corporation Multi-frequency neural treatments and associated systems and methods
US8808161B2 (en) 2003-10-23 2014-08-19 Covidien Ag Redundant temperature monitoring in electrosurgical systems for safety mitigation
US9278215B2 (en) 2011-09-08 2016-03-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9409019B2 (en) 2009-07-28 2016-08-09 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US9768373B2 (en) 2003-10-30 2017-09-19 Covidien Ag Switched resonant ultrasonic power amplifier system
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10493275B2 (en) 2009-04-22 2019-12-03 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US10799701B2 (en) 2016-03-30 2020-10-13 Nevro Corp. Systems and methods for identifying and treating patients with high-frequency electrical signals
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US11446504B1 (en) 2016-05-27 2022-09-20 Nevro Corp. High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
US11596798B2 (en) 2016-01-25 2023-03-07 Nevro Corp Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US11602634B2 (en) 2019-01-17 2023-03-14 Nevro Corp. Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB985987A (en) * 1960-04-07 1965-03-10 Kurt Koerber Method and apparatus for forming a uniform tobacco rod
US3645267A (en) * 1969-10-29 1972-02-29 Medtronic Inc Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate
US3669120A (en) * 1969-07-11 1972-06-13 Rovsing As Christian Device for starting or stimulating heart contractions
US3713449A (en) * 1970-08-31 1973-01-30 P Mulier Cardiac pacer with externally controllable variable width output pulse
US3796221A (en) * 1971-07-07 1974-03-12 N Hagfors Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means
US3830242A (en) * 1970-06-18 1974-08-20 Medtronic Inc Rate controller and checker for a cardiac pacer pulse generator means
US3865119A (en) * 1972-04-11 1975-02-11 Siemens Ag Heartbeat actuator with controlled pulse amplitude
US4124031A (en) * 1977-06-09 1978-11-07 Vitatron Medical B.V. Programmable pacer
US4285347A (en) * 1979-07-25 1981-08-25 Cordis Corporation Stabilized directional neural electrode lead
US4390023A (en) * 1981-04-30 1983-06-28 Medtronic, Inc. Patterned electrical tissue stimulator
US4440173A (en) * 1979-11-08 1984-04-03 Medtronic Programmable body stimulation system
US4538624A (en) * 1982-12-08 1985-09-03 Cordis Corporation Method for lead introduction and fixation
US4649936A (en) * 1984-10-11 1987-03-17 Case Western Reserve University Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB985987A (en) * 1960-04-07 1965-03-10 Kurt Koerber Method and apparatus for forming a uniform tobacco rod
US3669120A (en) * 1969-07-11 1972-06-13 Rovsing As Christian Device for starting or stimulating heart contractions
US3645267A (en) * 1969-10-29 1972-02-29 Medtronic Inc Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate
US3830242A (en) * 1970-06-18 1974-08-20 Medtronic Inc Rate controller and checker for a cardiac pacer pulse generator means
US3713449A (en) * 1970-08-31 1973-01-30 P Mulier Cardiac pacer with externally controllable variable width output pulse
US3796221A (en) * 1971-07-07 1974-03-12 N Hagfors Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means
US3865119A (en) * 1972-04-11 1975-02-11 Siemens Ag Heartbeat actuator with controlled pulse amplitude
US4124031A (en) * 1977-06-09 1978-11-07 Vitatron Medical B.V. Programmable pacer
US4285347A (en) * 1979-07-25 1981-08-25 Cordis Corporation Stabilized directional neural electrode lead
US4440173A (en) * 1979-11-08 1984-04-03 Medtronic Programmable body stimulation system
US4390023A (en) * 1981-04-30 1983-06-28 Medtronic, Inc. Patterned electrical tissue stimulator
US4538624A (en) * 1982-12-08 1985-09-03 Cordis Corporation Method for lead introduction and fixation
US4649936A (en) * 1984-10-11 1987-03-17 Case Western Reserve University Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking

Cited By (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188104A (en) * 1991-02-01 1993-02-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5263480A (en) * 1991-02-01 1993-11-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
WO1992013592A1 (en) * 1991-02-01 1992-08-20 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US6246912B1 (en) 1996-06-27 2001-06-12 Sherwood Services Ag Modulated high frequency tissue modification
USRE41045E1 (en) 1996-06-27 2009-12-15 Covidien Ag Method and apparatus for altering neural tissue function
USRE40279E1 (en) 1997-06-26 2008-04-29 Sherwood Services Ag Method and system for neural tissue modification
US7901400B2 (en) 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6895280B2 (en) 1999-07-27 2005-05-17 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US20050004628A1 (en) * 2002-03-15 2005-01-06 Medtronic, Inc Amplitude ramping of waveforms generated by an implantable medical device
US7526341B2 (en) * 2002-03-15 2009-04-28 Medtronic, Inc. Amplitude ramping of waveforms generated by an implantable medical device
US7749217B2 (en) 2002-05-06 2010-07-06 Covidien Ag Method and system for optically detecting blood and controlling a generator during electrosurgery
US7824400B2 (en) 2002-12-10 2010-11-02 Covidien Ag Circuit for controlling arc energy from an electrosurgical generator
US7722601B2 (en) 2003-05-01 2010-05-25 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US8012150B2 (en) 2003-05-01 2011-09-06 Covidien Ag Method and system for programming and controlling an electrosurgical generator system
US8104956B2 (en) 2003-10-23 2012-01-31 Covidien Ag Thermocouple measurement circuit
US8808161B2 (en) 2003-10-23 2014-08-19 Covidien Ag Redundant temperature monitoring in electrosurgical systems for safety mitigation
US9768373B2 (en) 2003-10-30 2017-09-19 Covidien Ag Switched resonant ultrasonic power amplifier system
US7766693B2 (en) 2003-11-20 2010-08-03 Covidien Ag Connector systems for electrosurgical generator
US7766905B2 (en) 2004-02-12 2010-08-03 Covidien Ag Method and system for continuity testing of medical electrodes
US7780662B2 (en) 2004-03-02 2010-08-24 Covidien Ag Vessel sealing system using capacitive RF dielectric heating
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US9522032B2 (en) 2005-10-21 2016-12-20 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
US8774926B2 (en) 2007-11-05 2014-07-08 Nevro Corporation Multi-frequency neural treatments and associated systems and methods
US8768472B2 (en) 2007-11-05 2014-07-01 Nevro Corporation Multi-frequency neural treatments and associated systems and methods
US10179241B2 (en) 2009-01-29 2019-01-15 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US10173065B2 (en) 2009-01-29 2019-01-08 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8509906B2 (en) 2009-01-29 2013-08-13 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US10918867B2 (en) 2009-01-29 2021-02-16 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US9403013B2 (en) 2009-01-29 2016-08-02 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8849410B2 (en) 2009-01-29 2014-09-30 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US11883670B2 (en) 2009-01-29 2024-01-30 Nevro Corp. Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US10245433B2 (en) 2009-04-22 2019-04-02 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333359B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8792988B2 (en) 2009-04-22 2014-07-29 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8718782B2 (en) 2009-04-22 2014-05-06 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8712533B2 (en) 2009-04-22 2014-04-29 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8862239B2 (en) 2009-04-22 2014-10-14 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8868192B2 (en) 2009-04-22 2014-10-21 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8874222B2 (en) 2009-04-22 2014-10-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8874221B2 (en) 2009-04-22 2014-10-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8874217B2 (en) 2009-04-22 2014-10-28 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8880177B2 (en) 2009-04-22 2014-11-04 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8886328B2 (en) 2009-04-22 2014-11-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8886327B2 (en) 2009-04-22 2014-11-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8886326B2 (en) 2009-04-22 2014-11-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8892209B2 (en) 2009-04-22 2014-11-18 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8989865B2 (en) 2009-04-22 2015-03-24 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11229792B2 (en) 2009-04-22 2022-01-25 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US10603494B2 (en) 2009-04-22 2020-03-31 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11229793B2 (en) 2009-04-22 2022-01-25 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11759638B2 (en) 2009-04-22 2023-09-19 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US10493275B2 (en) 2009-04-22 2019-12-03 Nevro Corp. Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US9327127B2 (en) 2009-04-22 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10471258B2 (en) 2009-04-22 2019-11-12 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9327125B2 (en) 2009-04-22 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9327126B2 (en) 2009-04-22 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333358B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333357B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8359103B2 (en) 2009-04-22 2013-01-22 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9333360B2 (en) 2009-04-22 2016-05-10 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9387327B2 (en) 2009-04-22 2016-07-12 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8694109B2 (en) 2009-04-22 2014-04-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10463857B2 (en) 2009-04-22 2019-11-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9480842B2 (en) 2009-04-22 2016-11-01 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US11786731B2 (en) 2009-04-22 2023-10-17 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8554326B2 (en) 2009-04-22 2013-10-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8718781B2 (en) 2009-04-22 2014-05-06 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8396559B2 (en) 2009-04-22 2013-03-12 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8355792B2 (en) 2009-04-22 2013-01-15 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8509905B2 (en) * 2009-04-22 2013-08-13 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8428748B2 (en) 2009-04-22 2013-04-23 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10195433B2 (en) 2009-04-22 2019-02-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10220209B2 (en) 2009-04-22 2019-03-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10220208B2 (en) 2009-04-22 2019-03-05 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US10226626B2 (en) 2009-04-22 2019-03-12 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US9409019B2 (en) 2009-07-28 2016-08-09 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US10258796B2 (en) 2010-11-30 2019-04-16 Nevro Corp. Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US8649874B2 (en) 2010-11-30 2014-02-11 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US9180298B2 (en) 2010-11-30 2015-11-10 Nevro Corp. Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US11883663B2 (en) 2011-09-08 2024-01-30 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9327121B2 (en) 2011-09-08 2016-05-03 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US10493277B2 (en) 2011-09-08 2019-12-03 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9295839B2 (en) 2011-09-08 2016-03-29 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9283388B2 (en) 2011-09-08 2016-03-15 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US11298539B2 (en) 2011-09-08 2022-04-12 Nevro Corp. Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9283387B2 (en) 2011-09-08 2016-03-15 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9278215B2 (en) 2011-09-08 2016-03-08 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US10328256B1 (en) 2012-06-22 2019-06-25 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US11247057B1 (en) 2012-06-22 2022-02-15 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US10751536B1 (en) 2013-06-10 2020-08-25 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US10576286B1 (en) 2013-11-07 2020-03-03 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10569089B1 (en) 2013-11-07 2020-02-25 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10556112B1 (en) 2013-11-07 2020-02-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US11596798B2 (en) 2016-01-25 2023-03-07 Nevro Corp Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US10799701B2 (en) 2016-03-30 2020-10-13 Nevro Corp. Systems and methods for identifying and treating patients with high-frequency electrical signals
US11446504B1 (en) 2016-05-27 2022-09-20 Nevro Corp. High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods
US11602634B2 (en) 2019-01-17 2023-03-14 Nevro Corp. Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods

Similar Documents

Publication Publication Date Title
US4735204A (en) System for controlling an implanted neural stimulator
USRE33420E (en) System for controlling an implanted neural stimulator
JP2823960B2 (en) Method and apparatus for limiting control of electrical tissue stimulator parameters
US5735887A (en) Closed-loop, RF-coupled implanted medical device
US6449512B1 (en) Apparatus and method for treatment of urological disorders using programmerless implantable pulse generator system
US9802048B2 (en) Variable output ramping for an implantable medical device
US8428731B2 (en) Sequenced therapy protocols for an implantable medical device
US7493165B2 (en) Implantable device and programmer system which permits multiple programmers
US5913882A (en) Neural stimulation techniques with feedback
US5058584A (en) Method and apparatus for epidural burst stimulation for angina pectoris
US7123967B2 (en) Implantable neural stimulation device providing activity, rest, and long term closed-loop peripheral vascular disease therapy and method
US6622038B2 (en) Treatment of movement disorders by near-diaphragmatic nerve stimulation
US7212863B2 (en) Implantable medical device operable in a special mode upon activation during a programmed time
US20060173493A1 (en) Multi-phasic signal for stimulation by an implantable device
EP3165255B1 (en) Optimization of application of current
KR20020040801A (en) Method to enhance cardiac capillary growth in heart failure patents
AU673109B2 (en) Cardiac pacemaker with triggered magnet modes
US6564100B2 (en) Cardiac rhythm management system with remotely activated capture verification for CHF and other patients
JPH04231973A (en) Vital tissue stimulator
EP1078651B1 (en) Implantable pacemaker and method of detecting a pacemaker mediated tachycardia

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 12